158 related articles for article (PubMed ID: 37243749)
1. Risk of estrogen receptor-specific breast cancer by family history of estrogen receptor subtypes and other cancers.
Wang QL; Zhang Y; Zeng E; Grassmann F; He W; Czene K
J Natl Cancer Inst; 2023 Sep; 115(9):1020-1028. PubMed ID: 37243749
[TBL] [Abstract][Full Text] [Related]
2. Family history of breast cancer in first-degree relatives and triple-negative breast cancer risk.
Phipps AI; Buist DS; Malone KE; Barlow WE; Porter PL; Kerlikowske K; Li CI
Breast Cancer Res Treat; 2011 Apr; 126(3):671-8. PubMed ID: 20814817
[TBL] [Abstract][Full Text] [Related]
3. Association between family history of cancer and breast cancer defined by estrogen and progesterone receptor status.
Tutera AM; Sellers TA; Potter JD; Drinkard CR; Wiesner GL; Folsom AR
Genet Epidemiol; 1996; 13(2):207-21. PubMed ID: 8722747
[TBL] [Abstract][Full Text] [Related]
4. Familial relative risks for breast cancer by pathological subtype: a population-based cohort study.
Mavaddat N; Pharoah PD; Blows F; Driver KE; Provenzano E; Thompson D; Macinnis RJ; Shah M; ; Easton DF; Antoniou AC
Breast Cancer Res; 2010; 12(1):R10. PubMed ID: 20146796
[TBL] [Abstract][Full Text] [Related]
5. Reproductive history and oral contraceptive use in relation to risk of triple-negative breast cancer.
Phipps AI; Chlebowski RT; Prentice R; McTiernan A; Wactawski-Wende J; Kuller LH; Adams-Campbell LL; Lane D; Stefanick ML; Vitolins M; Kabat GC; Rohan TE; Li CI
J Natl Cancer Inst; 2011 Mar; 103(6):470-7. PubMed ID: 21346227
[TBL] [Abstract][Full Text] [Related]
6. Analysis of Breast Cancer Family History, Estrogen Receptor Status, and Breast Cancer Outcomes in Sweden.
Zhang Y; Wang QL; Zeng E; He W; Czene K
JAMA Netw Open; 2023 Jun; 6(6):e2318053. PubMed ID: 37310740
[TBL] [Abstract][Full Text] [Related]
7. Risk Factors That Increase Risk of Estrogen Receptor-Positive and -Negative Breast Cancer.
Kerlikowske K; Gard CC; Tice JA; Ziv E; Cummings SR; Miglioretti DL;
J Natl Cancer Inst; 2017 May; 109(5):. PubMed ID: 28040694
[TBL] [Abstract][Full Text] [Related]
8. Predicting risk of breast cancer in postmenopausal women by hormone receptor status.
Chlebowski RT; Anderson GL; Lane DS; Aragaki AK; Rohan T; Yasmeen S; Sarto G; Rosenberg CA; Hubbell FA;
J Natl Cancer Inst; 2007 Nov; 99(22):1695-705. PubMed ID: 18000216
[TBL] [Abstract][Full Text] [Related]
9. Parity, hormones and breast cancer subtypes - results from a large nested case-control study in a national screening program.
Ellingjord-Dale M; Vos L; Tretli S; Hofvind S; Dos-Santos-Silva I; Ursin G
Breast Cancer Res; 2017 Jan; 19(1):10. PubMed ID: 28114999
[TBL] [Abstract][Full Text] [Related]
10. Relationship of established risk factors with breast cancer subtypes.
McCarthy AM; Friebel-Klingner T; Ehsan S; He W; Welch M; Chen J; Kontos D; Domchek SM; Conant EF; Semine A; Hughes K; Bardia A; Lehman C; Armstrong K
Cancer Med; 2021 Sep; 10(18):6456-6467. PubMed ID: 34464510
[TBL] [Abstract][Full Text] [Related]
11. Alcohol and postmenopausal breast cancer risk defined by estrogen and progesterone receptor status: a prospective cohort study.
Suzuki R; Ye W; Rylander-Rudqvist T; Saji S; Colditz GA; Wolk A
J Natl Cancer Inst; 2005 Nov; 97(21):1601-8. PubMed ID: 16264180
[TBL] [Abstract][Full Text] [Related]
12. Disparities in the risk of the ER/PR/HER2 breast cancer subtypes among Asian Americans in California.
Parise C; Caggiano V
Cancer Epidemiol; 2014 Oct; 38(5):556-62. PubMed ID: 25172158
[TBL] [Abstract][Full Text] [Related]
13. Mortality risk of black women and white women with invasive breast cancer by hormone receptors, HER2, and p53 status.
Ma H; Lu Y; Malone KE; Marchbanks PA; Deapen DM; Spirtas R; Burkman RT; Strom BL; McDonald JA; Folger SG; Simon MS; Sullivan-Halley J; Press MF; Bernstein L
BMC Cancer; 2013 May; 13():225. PubMed ID: 23642215
[TBL] [Abstract][Full Text] [Related]
14. Active smoking and the risk of estrogen receptor-positive and triple-negative breast cancer among women ages 20 to 44 years.
Kawai M; Malone KE; Tang MT; Li CI
Cancer; 2014 Apr; 120(7):1026-34. PubMed ID: 24515648
[TBL] [Abstract][Full Text] [Related]
15. Hormone receptor status of a first primary breast cancer predicts contralateral breast cancer risk in the WECARE study population.
Reiner AS; Lynch CF; Sisti JS; John EM; Brooks JD; Bernstein L; Knight JA; Hsu L; Concannon P; Mellemkjær L; Tischkowitz M; Haile RW; Shen R; Malone KE; Woods M; Liang X; Morrow M; Bernstein JL;
Breast Cancer Res; 2017 Jul; 19(1):83. PubMed ID: 28724391
[TBL] [Abstract][Full Text] [Related]
16. Estrogen receptor-positive, progesterone receptor-negative breast cancer: association with growth factor receptor expression and tamoxifen resistance.
Arpino G; Weiss H; Lee AV; Schiff R; De Placido S; Osborne CK; Elledge RM
J Natl Cancer Inst; 2005 Sep; 97(17):1254-61. PubMed ID: 16145046
[TBL] [Abstract][Full Text] [Related]
17. Distinct Effects of Body Mass Index and Waist/Hip Ratio on Risk of Breast Cancer by Joint Estrogen and Progestogen Receptor Status: Results from a Case-Control Study in Northern and Eastern China and Implications for Chemoprevention.
Wang F; Liu L; Cui S; Tian F; Fan Z; Geng C; Cao X; Yang Z; Wang X; Liang H; Wang S; Jiang H; Duan X; Wang H; Li G; Wang Q; Zhang J; Jin F; Tang J; Li L; Zhu S; Zuo W; Ma Z; Zhou F; Yu L; Xiang Y; Li L; Shen S; Yu Z
Oncologist; 2017 Dec; 22(12):1431-1443. PubMed ID: 28912152
[TBL] [Abstract][Full Text] [Related]
18. Association of hormone-related characteristics and breast cancer risk by estrogen receptor/progesterone receptor status in the shanghai breast cancer study.
Bao PP; Shu XO; Gao YT; Zheng Y; Cai H; Deming SL; Ruan ZX; Su Y; Gu K; Lu W; Zheng W
Am J Epidemiol; 2011 Sep; 174(6):661-71. PubMed ID: 21768404
[TBL] [Abstract][Full Text] [Related]
19. Family History of Cancer in Relation to Breast Cancer Subtypes in African American Women.
Bethea TN; Rosenberg L; Castro-Webb N; Lunetta KL; Sucheston-Campbell LE; Ruiz-Narváez EA; Charlot M; Park SY; Bandera EV; Troester MA; Ambrosone CB; Palmer JR
Cancer Epidemiol Biomarkers Prev; 2016 Feb; 25(2):366-73. PubMed ID: 26721669
[TBL] [Abstract][Full Text] [Related]
20. Familial risks and estrogen receptor-positive breast cancer in Hong Kong Chinese women.
Tse LA; Li M; Chan WC; Kwok CH; Leung SL; Wu C; Yu IT; Yu WC; Lao X; Wang X; Wong CK; Lee PM; Wang F; Yang XR
PLoS One; 2015; 10(3):e0120741. PubMed ID: 25756203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
